[Practical guidelines for the radiotherapy for patients presented with haematological malignancies in the epidemic COVID-19 situation: International Lymphoma Radiation Oncology Group recommendations].
Identifieur interne : 000126 ( Main/Exploration ); précédent : 000125; suivant : 000127[Practical guidelines for the radiotherapy for patients presented with haematological malignancies in the epidemic COVID-19 situation: International Lymphoma Radiation Oncology Group recommendations].
Auteurs : Y. Kirova [France]Source :
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [ 1769-6658 ] ; 2020.
Descripteurs français
- KwdFr :
- Betacoronavirus (MeSH), Humains (MeSH), Hypofractionnement de dose (MeSH), Infections à coronavirus (épidémiologie), Lymphomes (radiothérapie), Maladie de Hodgkin (radiothérapie), Organes à risque (effets des radiations), Pandémies (MeSH), Pneumopathie virale (épidémiologie), Radio-oncologie (normes), Tumeurs hématologiques (radiothérapie).
- MESH :
- effets des radiations : Organes à risque.
- normes : Radio-oncologie.
- radiothérapie : Lymphomes, Maladie de Hodgkin, Tumeurs hématologiques.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- Betacoronavirus, Humains, Hypofractionnement de dose, Pandémies.
English descriptors
- KwdEn :
- Betacoronavirus (MeSH), Coronavirus Infections (epidemiology), Hematologic Neoplasms (radiotherapy), Hodgkin Disease (radiotherapy), Humans (MeSH), Lymphoma (radiotherapy), Organs at Risk (radiation effects), Pandemics (MeSH), Pneumonia, Viral (epidemiology), Radiation Dose Hypofractionation (MeSH), Radiation Oncology (standards).
- MESH :
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- radiation effects : Organs at Risk.
- radiotherapy : Hematologic Neoplasms, Hodgkin Disease, Lymphoma.
- standards : Radiation Oncology.
- Betacoronavirus, Humans, Pandemics, Radiation Dose Hypofractionation.
DOI: 10.1016/j.canrad.2020.04.005
PubMed: 32402596
PubMed Central: PMC7198151
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Practical guidelines for the radiotherapy for patients presented with haematological malignancies in the epidemic COVID-19 situation: International Lymphoma Radiation Oncology Group recommendations].</title><author><name sortKey="Kirova, Y" sort="Kirova, Y" uniqKey="Kirova Y" first="Y" last="Kirova">Y. Kirova</name><affiliation wicri:level="3"><nlm:affiliation>Département de radiothérapie-oncologie, institut Curie, 25, rue d'Ulm, 75005 Paris, France. Electronic address: youlia.kirova@curie.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département de radiothérapie-oncologie, institut Curie, 25, rue d'Ulm, 75005 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32402596</idno><idno type="pmid">32402596</idno><idno type="doi">10.1016/j.canrad.2020.04.005</idno><idno type="pmc">PMC7198151</idno><idno type="wicri:Area/Main/Corpus">001325</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001325</idno><idno type="wicri:Area/Main/Curation">001325</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001325</idno><idno type="wicri:Area/Main/Exploration">001325</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Practical guidelines for the radiotherapy for patients presented with haematological malignancies in the epidemic COVID-19 situation: International Lymphoma Radiation Oncology Group recommendations].</title><author><name sortKey="Kirova, Y" sort="Kirova, Y" uniqKey="Kirova Y" first="Y" last="Kirova">Y. Kirova</name><affiliation wicri:level="3"><nlm:affiliation>Département de radiothérapie-oncologie, institut Curie, 25, rue d'Ulm, 75005 Paris, France. Electronic address: youlia.kirova@curie.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Département de radiothérapie-oncologie, institut Curie, 25, rue d'Ulm, 75005 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><series><title level="j">Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</title><idno type="eISSN">1769-6658</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term><term>Coronavirus Infections (epidemiology)</term><term>Hematologic Neoplasms (radiotherapy)</term><term>Hodgkin Disease (radiotherapy)</term><term>Humans (MeSH)</term><term>Lymphoma (radiotherapy)</term><term>Organs at Risk (radiation effects)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (epidemiology)</term><term>Radiation Dose Hypofractionation (MeSH)</term><term>Radiation Oncology (standards)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (MeSH)</term><term>Humains (MeSH)</term><term>Hypofractionnement de dose (MeSH)</term><term>Infections à coronavirus (épidémiologie)</term><term>Lymphomes (radiothérapie)</term><term>Maladie de Hodgkin (radiothérapie)</term><term>Organes à risque (effets des radiations)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (épidémiologie)</term><term>Radio-oncologie (normes)</term><term>Tumeurs hématologiques (radiothérapie)</term></keywords><keywords scheme="MESH" qualifier="effets des radiations" xml:lang="fr"><term>Organes à risque</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Radio-oncologie</term></keywords><keywords scheme="MESH" qualifier="radiation effects" xml:lang="en"><term>Organs at Risk</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Hematologic Neoplasms</term><term>Hodgkin Disease</term><term>Lymphoma</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Lymphomes</term><term>Maladie de Hodgkin</term><term>Tumeurs hématologiques</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Radiation Oncology</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>Humans</term><term>Pandemics</term><term>Radiation Dose Hypofractionation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Betacoronavirus</term><term>Humains</term><term>Hypofractionnement de dose</term><term>Pandémies</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32402596</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1769-6658</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>06</Month></PubDate></JournalIssue><Title>Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</Title><ISOAbbreviation>Cancer Radiother</ISOAbbreviation></Journal><ArticleTitle>[Practical guidelines for the radiotherapy for patients presented with haematological malignancies in the epidemic COVID-19 situation: International Lymphoma Radiation Oncology Group recommendations].</ArticleTitle><Pagination><MedlinePgn>194-195</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1278-3218(20)30101-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.canrad.2020.04.005</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kirova</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Département de radiothérapie-oncologie, institut Curie, 25, rue d'Ulm, 75005 Paris, France. Electronic address: youlia.kirova@curie.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D017065">Practice Guideline</PublicationType></PublicationTypeList><VernacularTitle>Guide pratique pour la radiothérapie des hémopathies malignes dans la situation d’épidémie de COVID-19 : recommandations de l’InternationalLymphomaRadiationOncologyGroup.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Cancer Radiother</MedlineTA><NlmUniqueID>9711272</NlmUniqueID><ISSNLinking>1278-3218</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019337" MajorTopicYN="N">Hematologic Neoplasms</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006689" MajorTopicYN="N">Hodgkin Disease</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008223" MajorTopicYN="N">Lymphoma</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058958" MajorTopicYN="N">Organs at Risk</DescriptorName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069473" MajorTopicYN="N">Radiation Dose Hypofractionation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018787" MajorTopicYN="N">Radiation Oncology</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword><Keyword MajorTopicYN="Y">Haematological malignancies</Keyword><Keyword MajorTopicYN="Y">Hémopathies malignes</Keyword><Keyword MajorTopicYN="Y">Radiotherapy</Keyword><Keyword MajorTopicYN="Y">Radiothérapie</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>03</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>04</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32402596</ArticleId><ArticleId IdType="pii">S1278-3218(20)30101-3</ArticleId><ArticleId IdType="doi">10.1016/j.canrad.2020.04.005</ArticleId><ArticleId IdType="pmc">PMC7198151</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blood. 2020 May 21;135(21):1829-1832</Citation><ArticleIdList><ArticleId IdType="pubmed">32275740</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Kirova, Y" sort="Kirova, Y" uniqKey="Kirova Y" first="Y" last="Kirova">Y. Kirova</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000126 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000126 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32402596
|texte= [Practical guidelines for the radiotherapy for patients presented with haematological malignancies in the epidemic COVID-19 situation: International Lymphoma Radiation Oncology Group recommendations].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32402596" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |